17 July 2025

FDA Haematology Pharmaceuticals

Myeloma drug scores FDA approval

17 July 2025

Pain Pharmaceuticals Research

First human evidence for resiniferatoxin in cancer pain

3 July 2025

PBAC Pharmaceuticals

Liver, endometrial and lung cancer drugs discussed at PBAC

19 June 2025

Breast cancer Genetics Pharmaceuticals

Potential classification, treatment changes in HER2 breast cancer

5 June 2025

Lung cancer PBS Pharmaceuticals

Targeted lung cancer therapy added to PBS

22 May 2025

Cancer Pharmaceuticals TGA

‘Important step forward’ in endometrial cancer treatment

22 May 2025

Leukaemia Pharmaceuticals

Statins linked to improved survival in leukaemia

8 May 2025

Pharmaceuticals Prostate cancer

Combination therapy shows promise for prostate cancer

10 April 2025

Leukaemia Pharmaceuticals

Real-world data backs AML treatment

27 March 2025

Hospitals Pharmaceuticals

Deprescribe, use the patient’s stash and shrink starter packs

27 February 2025

Pharmaceuticals TGA

TGA gives tislelizumab the thumbs up

27 February 2025

Leukaemia Pharmaceuticals

Infusion therapy for CLL could be a thing of the past

13 February 2025

Immunosuppression Pharmaceuticals

Use antivirals in patients at risk of hep B reactivation

14 November 2024

Melanoma & skin cancer Pharmaceuticals

10 years on, Nivo continues to increase melanoma survival

31 October 2024

Pharmaceuticals Sarcoidosis

What we neglect in sarcoidosis care

17 October 2024

Pharmaceuticals Rare cancers

Breast cancer drug also work for appendiceal cancer

5 September 2024

PBS Pharmaceuticals

Expanded PBS listing for cabozantinib

5 September 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

22 August 2024

Pain Pharmaceuticals

Choice of first opioid predicts long-term use

27 June 2024

Pharmaceuticals Systems

Weight-based pembrolizumab gives more bang for the public buck